CRISPR will save lives - and technology can't come soon

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
100
CRISPR will save lives - and technology can't come soon enough

This spooks me, but but big money could be made here, CRISPER stocks I will post later.

https://www.smh.com.au/technology/crispr-will...4z1n3.html

Humans have been tinkering with genes for as long we know. It’s why we have edible bananas instead of bulbous things with hard seeds, or corn that looks like corn and not grass. Well before the discovery of the gene, we’ve been breeding them in and out of plants and animals with absolutely no way of knowing what our introduced modifications do, where they end up in the genome, or how they might affect the environment.
Here’s the paradox: modern gene technology is far less genetically invasive – and much better understood – than the time-worn practice of selective breeding, and yet so many of us live in fear of genetically modified organisms. Instead of adding, removing, or reshuffling thousands of unknown genes in order to breed traits in or out of organisms, we’re now able to act on just one well-characterised gene with precision.
We didn’t need high-powered biotech to create dachshunds or bulldogs from ancestral wolves. The same breeding techniques that gave us virtually all of the food we now eat also has given our companions a predisposition to spinal problems and breathing difficulties.
Sinister. But short of us reverting to cave-dwellers, there really is no way out of it. Even kale, the staple crop of the inner city, started off as a weed.
Selective breeding is the cornerstone of agriculture, and civilisation might never have emerged without it. But compared with molecular methods, it’s like driving in a screw with a sledgehammer.
Enter CRISPR. This is a promising new gene editing technology that promises greater affordability and precision than ever before. It works by cutting through the DNA at a specific point, like a pair of molecular scissors. By taking advantage of the cell’s own DNA repair mechanisms, we’re able to insert, edit, or delete genes, in some cases down to a single unit of genetic code.
The potential applications of CRISPR are enormous. It’s the closest we’ve ever come to a cure for cancer. We’ve already been able to cure HIV infection in animal models, and even in human cell cultures, by removing the viral genes that insert themselves into our DNA. Incurable genetic diseases, like Duchenne’s muscular dystrophy, could soon be a thing of the past. CRISPR has already been used to cure the disease in rats.
But some are not so convinced. Couldn’t this technology be used to create a dystopia where only the rich can afford genetic enhancements to make themselves better, faster, stronger?

The short and long answer is no. There are limits to gene technology. When progressives shun gene technology for fear of creating a race of artificial super-humans, they unknowingly surrender to dangerous and discredited ideas that reek of the same eugenics they want to combat.
There are no “superior” genes, and therefore no way to create genetically superior humans. There are only genes that confer a selective advantage in a specific environment. Because I have darker skin, I’m less likely to develop melanoma. I’ve never even experienced sunburn. My skin colour is advantageous in sunny Australia, but not so useful in Scandinavia, where I could end up with a vitamin D deficiency.
Only a few traits are decisively linked to a single gene, like some types of red-green colourblindness (which, by the way, makes you better at seeing camouflage). But there’s no single genetic switch for abstract traits like intelligence or sexuality.

Even though there are a few dozen genes that are thought to contribute to intelligence, none of them do so in any way significant enough for us to modify. At best they contribute to a slightly increased probability, not a guarantee, that someone will be smarter. Some of them are also associated with schizophrenia, Alzheimer’s, and even obesity. Can you really call these genes superior? You’d be far better off getting a library membership.
Our genome is a biological balancing act, reliant on what is more advantageous to our survival. Even disease genes can be advantageous in certain environments. People with one copy of the sickle-cell disease gene, which causes a red blood cell deformity, are protected against malaria. This is largely why natural selection has not already created a race of super-humans. We are all born equal parts gifted and cursed.
Precisely because of this, CRISPR doesn’t even require us to insert any new genes at all for it to deliver. The chemical responsible for the browning of avocadoes is useful for the plant in the wild, but not so much when grown for agriculture. The same goes for allergens in nuts. With CRISPR, we can turn those genes off with minimal disruption to the genome.
It’s worth pointing out these gene deactivations crop up in nature all the time without any human intervention. A single genetic event was all it took to turn bitter almonds, containing lethal levels of cyanide, into the sweet variety we all love and enjoy.
The future of gene technology is a matter of public importance. CRISPR could revolutionise medicine and agriculture, but we still have a mountain to climb before we can put it to use. While we don’t think that there is a straightforward correspondence between genes and things like musical ability, we do think that such technology will have the potential to change things like hair, eye, and even skin colour. Where we should draw the line is up for debate. But one thing is clear: we need gene technology on our side.
It will be some time before we can say for certain that the technology is without side-effects, and even then there are challenges in getting the CRISPR mechanism into living cells. We’re getting there. But for some, the technology could not come soon enough. CRISPR will save lives.
Fahad Ali is a geneticist and member of the Sydney Nano Institute and the Sydney Institute of Agriculture. He works in developing novel delivery methods for the CRISPR mechanism in plant cells.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 201

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading
Bizzdesign Tops Gartner’s 2026 Enterprise Architecture List

Updated Category News Views 100

Enterprise Architecture’s Silent Backbone Sometimes it's the quiet operators like Bizzdesign that hijack the spotlight after years of steady steering. With the latest nod from Gartner, Bizzdesign is clearly on a tear in the enterprise architecture domain. In their 2026 Critical Capabilities report, Bizzdesign's products—Horizzon, Alfabet, and Hopex—secured top spots...

Continue Reading
PepsiCo Nears Deforestation-Free Sourcing Milestone by 2025

Updated Category News Views 129

PepsiCo's Aim for a Greener Supply Chain Well, look who's climbing the environmental ladder—PepsiCo. They’ve apparently hit 94% deforestation-free sourcing for those high-stakes commodities their empire relies on. Maybe it's a wake-up call for the rest of 'em still smogging about. The endgame? Full-fledged deforestation-free sourcing by 2030. That’s no walk in the...

Continue Reading
Priceline's Cyber Week: A Pocket-Friendly Travel Bonanza

Updated Category News Views 146

Unpacking Priceline's Cyber Week Bonanza Alright, folks, grab your booking hats because Priceline is back with its annual Cyber Week extravaganza, aiming to give travelers a shot in the arm of savings just when inflation has everyone pinching pennies. From November 16 through December 2, Priceline rolls out the red carpet for vacation planners, offering eye-popping...

Continue Reading
New York Reclaims Bagel Crown at 2026 BagelFest

Updated Category News Views 139

A Bagel Victory at Citi Field Holy schmear! New Yorker's are grinning wide like a bagel with a double helping of cream cheese—Ess-a-Bagel from Manhattan snagged the top honors at the heavily contested 2026 New York BagelFest. Back in its rightful hands, the Bagel Crown stays in the Empire State, and it's a victory for tradition and taste. Celebrating 50 years in the...

Continue Reading
Fortvita's Zybrivo Gains CHMP Nod: A European Leap

Updated Category News Views 103

It's not every day you're reading about a biotech making a ground-breaking shift off Chinese shores, but Fortvita's latest breakthrough is worth noting. Their fancy immunotherapy, Zybrivo® (sintilimab), just snagged a nod from the CHMP, Europe's committee that guides many on the medicinal merry-go-round. This isn't just your run-of-the-mill nod either. We're talking...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 254

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Exploring Why Dead Outlets Stay Dead: Expert Insights

Updated Category News Views 66

The Mystery of Non-Responsive Outlets Ever found an electrical outlet refusing to cooperate when you need it most? Well, I know the frustration all too well. You'd think if the breaker ain't blown, the outlet should work like a charm. But dive into the guts of the story, and you find a series of surprises waiting to trip us up. Common Culprits: Tripped GFCIs and Loose...

Continue Reading
Baidu's Q3 2026: AI Explodes Amid Marketing Slump

Updated Category News Views 35

Baidu Looks to AI as Revenue Driver in Q3 2026 You know, Baidu's got one heck of a story this quarter. Despite some clouds hanging over them, they’ve managed to find a silver lining in their AI ventures. It’s like they’ve got this magic bullet with AI Cloud growth skyrocketing 94% year over year. That’s not just a rabbit outta the hat; it’s more like pulling a...

Continue Reading
MacKenzie-Childs Grinds Into Spotlight with Oprah's Nod

Updated Category News Views 50

Oprah's Golden Touch: 30 Years Strong Every year, there are a few select spots that brands covet like a hawk on a rabbit hunt. Getting on Oprah’s 'Favorite Things' list is surely one of them. Just like that, the MacKenzie-Childs Electric Salt and Pepper Grinder Set has muscled its way into the 2026 selection. Spare me the bells and whistles; this is like hitting the...

Continue Reading

Top 5 Most Recently Viewed Articles

Citi Raises Price Target for Blackstone Amid Encouraging Outlook

Updated Category News Views 131

Citi's Updated Outlook on Blackstone Recently, Citi revisited its financial forecast for The Blackstone Group (NYSE: BX), adjusting the price target upward from $157.00 to $170.00 while maintaining a Neutral stance on the stock. This update follows the company's impressive third-quarter performance, which saw Blackstone's stock rise by 6.3% post-earnings announcement....

Continue Reading
JAB's Strategic Acquisition of Mondelez Shares in JDE Peet's

Updated Category News Views 92

JAB's Significant Move in the Coffee Industry In a strategic and noteworthy development, JAB has made headlines by agreeing to acquire a substantial share package from Mondelez, focusing on Dutch coffee giant JDE Peet's. This major transaction amounts to approximately €2.2 billion, or about $2.4 billion. JAB intends to purchase 86 million shares at a price of €25.10...

Continue Reading
Urgent Update for DXC Technology Company Investors

Updated Category News Views 272

DXC Technology Company (NYSE: DXC) found itself in hot water back in 2024 when shareholders raised hell over alleged falsehoods that inflated stock prices. The Rosen Law Firm rolled out a class action lawsuit aimed at those who bought shares during what they dubbed the Class Period—a time rife with questionable operational claims from DXC's brass. Allegations Surface:...

Continue Reading
Investigation Launched: National Grid Faces Legal Scrutiny

Updated Category News Views 283

Bragar Eagel & Squire, P.C. Initiates Investigation Bragar Eagel & Squire, P.C., a well-regarded law firm known for advocating for investors, has begun an investigation surrounding concerns related to National Grid plc (NYSE: NGG). This inquiry primarily aims to assist stockholders who may have experienced losses while owning shares of National Grid. The firm invites...

Continue Reading
Oil & Gas Sector Trends: Path to 8.79 Trillion Growth

Updated Category News Views 223

Oil & Gas Market Growth and Projections The global oil and gas market has positioned itself for remarkable expansion. With estimates currently valuing the market at approximately USD 6.10 trillion, projections suggest it could soar to around USD 8.79 trillion by 2034. This growth translates to a compound annual growth rate (CAGR) of 3.72% between 2025 and 2034. Notably,...

Continue Reading